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Abstract
To date, the problem of HBV-infection in pregnant women remains relevant and one of the most important for medical science
and health care, as it can be considered as a maternal-fetal infection.
The aim of the research is to investigate the course of HBV-infection in pregnant women, depending on the duration of the
disease, the degree of viremia and the activity of hepatitis, taking into account gestational periods.
Materials and methods. The course of pregnancy in 142 women aged 18-35 years with HBV-infection was monitored.
Serum markers and viral load (VL) of hepatitis B (HB) were determined, as well as the levels of ALT, AST, thymol test, serum
bilirubin levels during each trimester of pregnancy.
Results. In pregnant women with HBV-infection, HBsAg-carriage was most often diagnosed, and the replication stages were
less frequent (96 and 46, respectively).
Clinical picture of the immune-active phase of chronic HBV-infection was oligosymptomatic without violation of pigment
metabolism and manifestations of mesenchymal-inflammatory reaction. The minimal degree of cytolysis prevailed, which
did not depend on the degree of the viremia. In women with immune-tolerant phase of cytolysis during pregnancy was not
observed.
In pregnant women with replication stage of HBV-infection and low degree of viremia, the VL increased at 1-2 log compared
to the second and third trimesters, and in women with high viremia – at 2-3 log.
In most women-carriers of HBsAg moderate degree of viremia predominated, and in the rest – it was not determined.
During the entire pregnancy, the immune-tolerant phase of chronic HBV-infection was latent and did not transform into the
immune-active phase.
Conclusion. Thus, the diagnosis of chronic HBV-infection was verified before pregnancy in 2.8 %, and during pregnancy
– in 97.2 % of women. Carriage of HBsAg prevailed in them (67.6 %), and replicative forms were registered in 32.4 % of
patients. The peculiarity of replicative forms is subclinical (65.3 %) and asymptomatic (34.7 %) clinical course with low VL (?
105 copies/mL), which in most cases (91.3 %) increases before delivery at 1-2 log and is accompanied by low activity of
hepatitis, without violation of pigment metabolism.
Keywords
HBV-infection; pregnant women
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
*Corresponding author: maranammv@gmail.com
Problem statement and analysis of the
recent research
In recent years, viral hepatitis (VH) has become not only a
great medical problem but also socio-economic one. Accord-
ing to various estimates, about 2 billion people in the world
are infected with hepatitis B virus (HBV) and 300-450 million
patients with chronic HBV (CHB), who are a constant source
of infection [7, 8, 9].
In Ukraine, among the adult population, the average inci-
dence of HBsAg carriers is 2.2 %, and the incidence of HBV
infection in pregnant women exceeds 18 % [1, 2].
An important peculiarity of the age structure of patients
with CHB in adults is its prevalence in young people of repro-
ductive age (19-29 and 30-39 years), which promotes further
activation of the sexual transmission of pathogen HBV, the
growth of infection in pregnant women, more intense perinatal
infection of newborns with HBV [6].
The problem of HBV-infection is one of the most urgent
in modern medicine, as it is a frequent cause of chronic liver
diseases in women of childbearing age. It is common for
obstetricians, infectiologists, hepatologists, pediatricians, and
therapists and requires the development of general strategy as
for the pregnancy management in such women [3, 5].
According to the recommendations of WHO and the Eu-
ropean Association for the Study of Liver, for women with
HBV-infection who have not reached the stage of cirrhosis, as
well as in the absence of signs of active inflammatory process
in the liver or cholestasis, pregnancy is not contraindicated,
since it does not have a negative effect on the course of CHB
[1, 5]. The results of research in this area are somewhat con-
troversial, however, most authors concluded that pregnancy
does not affect the course of CHB [3, 5, 8, 9].
Because of the negative impact on the maternal and fe-
tal health, the infection caused by HBV is a global medical
and social problem in many countries of the modern world.
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Therefore, knowledge of the natural course of HBV-infection
in pregnant women is necessary to optimize the tactics of their
management [3].
Objective of the study – is to investigate the course of
HBV-infection in pregnant women, depending on the dura-
tion of the disease, the degree of viremia and the activity of
hepatitis, taking into account gestational periods.
1. Materials and methods of the research
We monitored the pregnancy course in 142 women aged 18-
35 years with HBV-infection. Serum markers of HB (HB-
sAg, anti-HBcIgM, anti-HBcIgG) were determined during
women’s registering in antenatal clinic. In women with de-
tected serological markers, HBV DNA was determined by
polymerase chain reaction (PCR) – qualitative and quantita-
tive (viral load (VL)) in the second and third trimesters of
pregnancy. The activity of the inflammatory process in the
liver by ALT, AST levels detection in blood serum during each
trimester of pregnancy was monitored. The level of bilirubin
and thymol test were also determined.
2. Results of research
The diagnosis of chronic HBV-infection has been verified in
142 pregnant women: before pregnancy in 4 (2.8 %), and
during pregnancy – in 138 (97.2 %). Most often, the carriage
of HBsAg was diagnosed as an integrative stage of the infec-
tion – in 96 (67.6 %) women, rarely the replication stage was
detected in 46 (32.4 %) women, of which the immunoactive
phase was in 14 (30.4 %), and the immunotolerant – in 32
(69.6 %) patients.
We did not observe any clinical manifestations of chronic
HBV-infection in the replicative stage, except for increased
fatigue in 16 (34.8 %) pregnant women and periodic discom-
fort in the right hypochondrium in 9 (19.6 %). Only in 5 (10.9
%) patients with the immunoactive phase hepatomegaly was
detected without violation of pigment metabolism and man-
ifestations of mesenchymal-inflammatory reaction (normal
levels of bilirubin, thymol tests, absence of hypergammaglob-
ulinemia).
In such women in 28.2 % of cases minimal, in 2.2 % –
moderate degrees of cytolysis were observed, which did not
depend on the degree of viremia. In the remaining 32 (69.6
%) women with immunotolerant phase of cytolysis during
pregnancy was not observed.
In the dynamics, as a rule, before delivery, in women
with a replicative stage of HBV-infection and low degree of
viremia (VL < 103 copies/mL), VL increased at 1-2 log (91.3
%) compared with II and III trimesters, and in women with
high viremia (VL = 105 copies/mL) – at 2-3 log (4.3 %). In
1 woman (2.2 %), the degree of viremia from boundary level
(= 750 copies/mL) without cytolysis was transformed in the
second trimester of pregnancy into moderate level (VL = 103
copies/mL) with a minimal activity level in III trimester. In
one woman (2.2 %) on the contrary – viremia from moderate
level in the second trimester (VL = 104 copies/mL) decreased
to the boundary one with normal ALT level in III trimester.
In the majority of women (53.1 %), HBsAg carriage was
accompanied by VL <104 copies/mL, and in 45 (46.9 %) it
was not determined. During the entire pregnancy, the immuno-
tolerant phase of chronic HBV-infection in women was latent
and did not transform into the immunoactive phase.
3. Discussion
According to current research data, HBV-infection in pregnant
women is usually asymptomatic, mainly in chronic form (97.4
%). The frequency of the integrative stage of the pathogen
reproduction predominates over the replicative (79.1 versus
8.7 %). Their diagnostics in pregnant women is difficult, since
both forms occur without jaundice and subjective manifesta-
tions of the disease, with the exception of the fact that replica-
tive HBV-infection is characterized by asthenic (90-93 %) and
dyspeptic (35-40 %) syndromes, hepatosplenomegaly (35-40
%), mesenchymal-inflammatory (32-36 %) and cholestatic
syndromes (20-25 %), as well as minor liver function disor-
ders, manifested by cytolysis syndrome in 50-52 % of patients,
which coincides with our data [1, 5, 6, 8].
Concerning the cytolysis levels, the results of our study
coincide with the authors’ research data, which indicate that
in part of pregnant women (48-50 %), despite the replication
of the virus, the level of ALT in serum can remain within the
normal range throughout the pregnancy. At the same time, in
HBsAg-positive pregnant women there were described cases
that indicate on deterioration of the liver function even the
development of fulminant hepatic failure [4, 5, 9].
According to some observations of other authors, during
pregnancy in women with CHB thymol test increases, serum
transaminases levels decrease against the background of nor-
mal levels of bilirubin and other biochemical indexes, amount
of virus circulating in the blood decreases, which may be
due to changes of immunological reactivity of the pregnant
women organisms and increased plasma concentrations of
estrogens [2, 6, 7, 8].
Pereverten L. I. and co-authors (2014) indicate the inten-
sive replication of the HBV in the first trimester of pregnancy,
with a subsequent decrease in the level of viremia before child-
birth (in the third trimester of pregnancy positive results of
PCR were obtained in 28 % of women) [5]. Chuikova K. I.
and co-authors (2011), by contrast, investigated the increase
in the level of viral replication up to 36 weeks of gestation,
which coincides with our study [6].
4. Prospects of further research
Prospects of further research will be aimed at study of the risk
factors that contribute to perinatal infection of the fetus.
5. Conclusion
Thus, the diagnosis of chronic HBV-infection was verified
before pregnancy in 2.8 %, and during pregnancy – in 97.2 %
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of women. Carriage of HBsAg prevailed in them (67.6 %),
and replicative forms were registered in 32.4 % of patients.
The peculiarity of replicative forms is subclinical (65.3 %) and
asymptomatic (34.7 %) clinical course with low VL (< 105
copies/mL), which in most cases (91.3 %) increases before
delivery at 1-2 log and is accompanied by low activity of
hepatitis, without violation of pigment metabolism.
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